$48.7M in CY2024 Part D spend1.1M claims · 322K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Raloxifene used for?
Raloxifene hydrochloride is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. ( 1.1 ) Reduction in risk of invasive breast cancer in po....
Is there a generic for Raloxifene?
Yes. 8 ANDAs filed at FDA, 8 generic manufacturers currently shipping.
How much does my plan pay for Raloxifene?
Across 329 Part D plans, Raloxifene averages $0.248/unit (NADAC). Lowest available: $0.248/unit. Highest in distribution: $0.248/unit.
Is Raloxifene on the FDA shortage list?
No. Raloxifene is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (9 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.